UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge

Emerging microbes & infections, 2022-12, Vol.11 (1), p.811-814

2022

Volltextzugriff (PDF)

EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase-producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations

BMC microbiology, 2020-07, Vol.20 (1), p.220-220, Article 220

2020

Volltextzugriff (PDF)

Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa

Emerging microbes & infections, 2023-12, Vol.12 (1), p.2179344-2179344

2023

Volltextzugriff (PDF)

Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosa

Antibiotics (Basel), 2020-11, Vol.9 (11), p.738

2020

Volltextzugriff (PDF)

Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients

Antimicrobial resistance & infection control, 2022-11, Vol.11 (1), p.146-146, Article 146

2022

Volltextzugriff (PDF)

Comparison of Zinc Concentrations in the Broth of Commercial Automated Susceptibility Testing Devices (Vitek 2, MicroScan, BD Phoenix, and Sensititre)

Microbiology spectrum, 2022-04, Vol.10 (2), p.e0005222-e0005222

2022

Volltextzugriff (PDF)

In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales

Journal of antimicrobial chemotherapy, 2023-12, Vol.78 (12), p.2801-2809

2023

Volltextzugriff (PDF)

Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population

Annals of hematology, 2024-05, Vol.103 (5), p.1745-1752

2024

Volltextzugriff (PDF)

Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases

Journal of antimicrobial chemotherapy, 2023-08, Vol.78 (8), p.1843-1847

2023

Volltextzugriff (PDF)

In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model

Antimicrobial agents and chemotherapy, 2023-05, Vol.67 (5), p.e0173822-e0173822

2023

Volltextzugriff (PDF)

In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2022-09, Vol.77 (10), p.2803-2808

2022

Volltextzugriff (PDF)

Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures

Journal of antimicrobial chemotherapy, 2024-03, Vol.79 (3), p.546-551

2024

Volltextzugriff (PDF)

Piperacillin/Tazobactam Dose Optimization in the Setting of Piperacillin/Tazobactam-susceptible, Carbapenem-resistant Pseudomonas aeruginosa: Time to Reconsider Susceptible Dose Dependent

Clinical therapeutics, 2023-01, Vol.45 (1), p.72-77

2023

Volltextzugriff (PDF)

Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa

Journal of clinical microbiology, 2020-05, Vol.58 (6)

2020

Volltextzugriff (PDF)

In vivo activity of WCK 4282 (high-dose cefepime/tazobactam) against serine β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa in the neutropenic murine thigh infection model

Journal of antimicrobial chemotherapy, 2021-03, Vol.76 (4), p.993-1000

2021

Volltextzugriff (PDF)

In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii

Journal of antimicrobial chemotherapy, 2023-04, Vol.78 (4), p.983-990

2023

Volltextzugriff (PDF)

Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48

Journal of antimicrobial chemotherapy, 2023-03, Vol.78 (3), p.636-645

2023

Volltextzugriff (PDF)

Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians

Journal of antimicrobial chemotherapy, 2023-09, Vol.78 (9), p.2242-2253

2023

Volltextzugriff (PDF)

Efficacy of human-simulated exposures of meropenem/vaborbactam and meropenem against OXA-48 β-lactamase-producing Enterobacterales in the neutropenic murine thigh infection model

Journal of antimicrobial chemotherapy, 2021-01, Vol.76 (1), p.184-188

2021

Volltextzugriff (PDF)

Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models

Journal of antimicrobial chemotherapy, 2021-09, Vol.76 (10), p.2615-2621

2021

Volltextzugriff (PDF)

The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa

European journal of clinical microbiology & infectious diseases, 2021-12, Vol.40 (12), p.2533-2541

2021

Volltextzugriff (PDF)

Human-Simulated Antimicrobial Regimens in Animal Models: Transparency and Validation Are Imperative

Antimicrobial agents and chemotherapy, 2020-07, Vol.64 (8)

2020

Volltextzugriff (PDF)

Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48

Journal of antimicrobial chemotherapy, 2022-09, Vol.77 (10), p.2622-2631

2022

Volltextzugriff (PDF)

Evaluation of a Phenotypic Algorithm to Direct Carbapenemase Testing in Pseudomonas aeruginosa : Validation in a Multicenter German Cohort

Microbial drug resistance (Larchmont, N.Y.), 2021-09, Vol.27 (9), p.1243-1248

2021

Volltextzugriff (PDF)

Retracted and replaced: Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48

Journal of antimicrobial chemotherapy, 2022-10, Vol.77 (10), p.2622-2631

2022

Volltextzugriff (PDF)

1 – 25 von 379

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(314)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(254)
Life Sciences & Biomedicine
(222)
Humans
(157)
Male
(85)
Female
(83)
Middle Aged
(50)
Adult
(45)
Infectious Diseases
(44)
Microbiology
(42)
Aged
(37)
Emergency Medicine
(31)
Pharmacology & Pharmacy
(31)
Biological And Medical Sciences
(27)
Public, Environmental & Occupational Health
(27)
Animals
(25)
Risk Factors
(25)
Medical Sciences
(24)
Emergency Medical Services
(23)
Patients
(23)
Retrospective Studies
(23)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(182)
EZB Electronic Journals Library
(180)
LWW Total
(161)
Ingenta
(127)
NUS Single-Journal Subscriptions
(101)
IngentaConnect Journals
(67)
Elsevier ScienceDirect Journals Complete
(52)
Oxford Journals
(35)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(32)
Wiley Online Library
(31)
Oxford Journals 2020 Medicine
(30)
Taylor & Francis Journals
(28)
Taylor & Francis Online
(27)
Taylor & Francis 数据库
(27)
SpringerLink_现刊
(24)
Wiley Online Library Full Collection 2018
(19)
JSTOR
(17)
Springer Nature - Connect here FIRST to enable access
(17)
IEEE Explore
(15)
Nexis Uni
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge

EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase-producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations

Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa

Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosa

Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients

Comparison of Zinc Concentrations in the Broth of Commercial Automated Susceptibility Testing Devices (Vitek 2, MicroScan, BD Phoenix, and Sensititre)

In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales

Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population

Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases

In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model

In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa

Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures

Piperacillin/Tazobactam Dose Optimization in the Setting of Piperacillin/Tazobactam-susceptible, Carbapenem-resistant Pseudomonas aeruginosa: Time to Reconsider Susceptible Dose Dependent

Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa

In vivo activity of WCK 4282 (high-dose cefepime/tazobactam) against serine β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa in the neutropenic murine thigh infection model

In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii

Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48

Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians

Efficacy of human-simulated exposures of meropenem/vaborbactam and meropenem against OXA-48 β-lactamase-producing Enterobacterales in the neutropenic murine thigh infection model

Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models

The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa

Human-Simulated Antimicrobial Regimens in Animal Models: Transparency and Validation Are Imperative

Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48

Evaluation of a Phenotypic Algorithm to Direct Carbapenemase Testing in Pseudomonas aeruginosa : Validation in a Multicenter German Cohort

Retracted and replaced: Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48

Suchergebnisse filtern